Nicolas Girard
机构：Institut Curie · ORCID：0000-0001-9909-2299
发表论文 904 篇 · 总被引 33473 次 · h-index 82
代表论文
- Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer (2025 · New England Journal of Medicine · 被引 52)
- Ifinatamab Deruxtecan in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Analysis of the Phase II IDeate-Lung01 Trial (2025 · Journal of Clinical Oncology · 被引 28)
- Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group (2025 · Lung Cancer · 被引 10)
- Sparing effects of FLASH irradiation in patient-derived lung tissue (2025 · Radiotherapy and Oncology · 被引 8)
- Surgical Results after Neoadjuvant Nivolumab and Platinum-based Chemotherapy for Resectable Lung Cancer. A Multicentre European Real Clinical Practice Analysis (2025 · European Journal of Cardio-Thoracic Surgery · 被引 3)
- International Thymic Malignancy Interest Group Standard Definitions, Policies, and Reporting Measures for Thymic Epithelial Tumors (2025 · Journal of Thoracic Oncology · 被引 3)